Literature DB >> 8089061

Liposomal amphotericin B and continuous venous-venous haemofiltration.

H Humphreys, D A Oliver, R Winter, D W Warnock.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8089061     DOI： 10.1093/jac/33.5.1070-a

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  5 in total

1.  [Not Available].

Authors:  M Tomlin; A Basarab; D Warnock
Journal:  Clin Drug Investig       Date:  1997       Impact factor: 2.859

Review 2.  Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.

Authors:  Romuald Bellmann; Piotr Smuszkiewicz
Journal:  Infection       Date:  2017-07-12       Impact factor: 3.553

Review 3.  Liposomal amphotericin B. Therapeutic use in the management of fungal infections and visceral leishmaniasis.

Authors:  A J Coukell; R N Brogden
Journal:  Drugs       Date:  1998-04       Impact factor: 9.546

4.  Pharmacokinetics of liposomal amphotericin B (Ambisome) in critically ill patients.

Authors:  V Heinemann; D Bosse; U Jehn; B Kähny; K Wachholz; A Debus; P Scholz; H J Kolb; W Wilmanns
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

5.  Elimination of liposomal amphotericin by hemodiafiltration.

Authors:  M Tomlin; G S Priestley
Journal:  Intensive Care Med       Date:  1995-08       Impact factor: 17.440
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.